​

Phathom Pharmaceuticals Ownership | Who Owns Phathom Pharmaceuticals?

OverviewForecastRevenueFinancialsChartTranscripts

Phathom Pharmaceuticals Ownership Summary

Phathom Pharmaceuticals is owned by 112.40% institutional investors, 7.70% insiders. Frazier life sciences management is the largest institutional shareholder, holding 17.32% of PHAT shares. Invesco OFI Global Equity is the top mutual fund, with 2.89% of its assets in Phathom Pharmaceuticals shares.

PHAT Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockPhathom Pharmaceuticals112.40%7.70%-20.09%
SectorHealthcare Stocks 88.01%8.90%3.09%
IndustryBiotech Stocks 109.70%8.77%-18.47%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Frazier life sciences management10.11M17.32%$104.13M
Medicxi ventures management (jersey)7.46M11.55%$60.61M
Jennison associates7.06M10.93%$57.35M
Carlyle group3.50M5.99%$35.84M
Invesco3.14M5.39%$32.38M
Blackrock2.93M5.01%$30.14M
Ensign peak advisors2.24M3.85%$23.12M
Vanguard group2.21M3.79%$22.78M
Nea management company1.96M3.36%$20.19M
Avidity partners management lp1.62M2.78%$16.69M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Medicxi ventures management (jersey)7.46M11.46%$60.61M
Propel bio management869.93K5.81%$8.96M
Catalys pacific721.96K5.61%$7.44M
Checkpoint capital875.00K5.43%$9.01M
Frazier life sciences management10.11M4.87%$104.13M
Carlyle group3.50M3.40%$35.84M
Decheng capital850.00K2.68%$8.76M
Saturn v capital management593.31K2.31%$6.11M
Oracle investment management225.00K2.16%$2.32M
Ghost tree capital600.00K1.94%$6.18M

Top Buyers

HolderShares% AssetsChange
Jennison associates7.06M0.03%1.20M
Portolan capital management1.13M0.96%1.13M
Morgan stanley762.60K0.00%525.44K
Gilder gagnon howe1.47M0.19%454.64K
Checkpoint capital875.00K5.43%429.84K

Top Sellers

HolderShares% AssetsChange
Octagon capital advisors lp---455.00K
683 capital management1.40M1.09%-250.00K
Millennium management---225.02K
Newtyn management---165.00K
Two sigma investments, lp303.43K0.01%-164.02K

New Positions

HolderShares% AssetsChangeValue
Portolan capital management1.13M0.96%1.13M$11.64M
Prudential financial352.34K0.01%352.34K$3.63M
Oracle investment management225.00K2.16%225.00K$2.32M
Mml investors services19.60K0.00%19.60K$202.00K
Corebridge financial18.36K0.00%18.36K$189.09K

Sold Out

HolderChange
Nelson, van denburg & campbell wealth management group-7.00
Bessemer group-325.00
Aquatic capital management-500.00
Vestcor-548.00
Ica group wealth management-1.30K

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 202413818.97%72,638,51228.44%1121.21%8528.79%20-
Jun 30, 2024115-1.71%56,555,1598.24%961.17%6624.53%19-44.12%
Mar 31, 2024117-2.50%52,249,16711.99%911.35%53-28.38%3447.83%
Dec 31, 20231206.19%46,653,5756.61%821.01%7417.46%23-4.17%
Sep 30, 20231134.63%43,760,2702.29%900.88%63-7.35%2420.00%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Invesco OFI Global Equity1.98M2.89%252.08K
Invesco Global A1.98M2.89%-
Jennison Health Sciences Equity1.78M2.61%-191.41K
PGIM Jennison Health Sciences Z1.78M2.61%-
Vanguard Total Stock Mkt Idx Inv1.59M2.32%-
Jennison SMid Cap Core Equity1.58M2.31%716.54K
PGIM Jennison Small Company A1.58M2.31%-
Strategic Advisers U.S. Total Stock{mg}1.48M2.16%-273.72K
Strategic Advisers Small-Mid Cap1.24M1.82%278.88K
Fidelity Select Biotechnology1.21M1.77%-

Recent Insider Transactions

DateNameRoleActivityValue
Jan 21, 2025Henderson Molly CFO and CBOSell$43.37K
Jan 21, 2025Nabulsi Azmi Chief Operating OfficerSell$51.96K
Jan 21, 2025Curran Terrie President and Chief ExecutiveSell$125.88K
Dec 19, 2024Nabulsi Azmi Chief Operating OfficerSell$8.94K
Dec 19, 2024Henderson Molly CFO and CBOSell$10.33K

Insider Transactions Trends

DateBuySell
2024 Q422
2024 Q3-3
2024 Q2-1
2024 Q1-3
2023 Q433

PHAT Ownership FAQ

Who Owns Phathom Pharmaceuticals?

Phathom Pharmaceuticals shareholders are primarily institutional investors at 112.40%, followed by 7.70% insiders and -20.10% retail investors. The average institutional ownership in Phathom Pharmaceuticals's industry, Biotech Stocks , is 109.70%, which Phathom Pharmaceuticals exceeds.

Who owns the most shares of Phathom Pharmaceuticals?

Phathom Pharmaceuticals’s largest shareholders are Frazier life sciences management (10.11M shares, 17.32%), Medicxi ventures management (jersey) (7.46M shares, 11.55%), and Jennison associates (7.06M shares, 10.93%). Together, they hold 39.80% of Phathom Pharmaceuticals’s total shares outstanding.

Does Blackrock own Phathom Pharmaceuticals?

Yes, BlackRock owns 5.01% of Phathom Pharmaceuticals, totaling 2.93M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 30.14M$. In the last quarter, BlackRock increased its holdings by 180.99K shares, a 6.59% change.

Who is Phathom Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Medicxi ventures management (jersey) is Phathom Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 11.46% of its assets in 7.46M Phathom Pharmaceuticals shares, valued at 60.61M$.

Who is the top mutual fund holder of Phathom Pharmaceuticals shares?

Invesco OFI Global Equity is the top mutual fund holder of Phathom Pharmaceuticals shares, with 2.89% of its total shares outstanding invested in 1.98M Phathom Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools